Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Hobot
Christipher M. Hobot, Tonka Bay, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20110066029 | Electromagnetic Medical Device - An insertable or implantable medical device includes an elongated member having a proximal end, a distal end, at least one conductive coil near the distal end, and electrical conductors which carry current from the coil towards the proximal end. The coil surrounds or is surrounded by a flexible magnetic polymeric composite. | 03-17-2011 |
Christopher Hobot, Brooklyn Park, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20100181210 | Point of Care Heparin Determination System - Methods and devices for point of care determination of heparin concentration in blood are described. Cartridges including protamine ion sensitive electrodes (ISEs) and reference electrodes and systems for automatically determining heparin concentration in the cartridges are provided. Some systems add blood to a protamine bolus sufficient to bind all heparin, leaving excess protamine. The excess protamine concentration can be determined by measuring the initial slope of the electrode potential rate of change, and comparing the slope to known protamine concentration slope values In some cartridges, an oscillating pressure source moves the blood-protamine mixture back and forth across the protamine ISE. Some systems also use a second blood sample having the heparin removed or degraded to create a blank reference sample. Protamine ISEs can include polyurethane polymer, DNNS ionophore, and NPOE plasticizer. The polyurethane may include hard segments and soft segments, where both hard and soft segments may include cyclic and straight chain aliphatic moieties having essentially no ester or ether groups. Some hard segments may include methylene diphenyl groups. Some reference electrodes have the same polymer, plasticizer, and ionophore as the measurement electrode, but with a different concentration of ionophore. | 07-22-2010 |
Christopher M. Hobot, Memphis, TN US
| Patent application number | Description | Published |
|---|---|---|
| 20090263455 | Dexamethasone Formulations in a Bioegradable Material - Effective treatments of acute pain for extended periods of time are provided. Through the administration of an effective amount of dexamethasone at or near a target site, one can relieve pain cause by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discongenic back pain and joint pain as well as pain that is incidental to surgery. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least twenty-five days. In some embodiments, the relief can be for at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days. | 10-22-2009 |
Christopher M. Hobot, Minneapolis, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20090264478 | SULFASALAZINE FORMULATIONS IN A BIODEGRADABLE POLYMER CARRIER - Effective treatments of acute pain and/or inflammation for extended periods of time are provided. Through the administration of an effective amount of sulfasalazine at or near a target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain as well as pain that is incidental to surgery. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days. | 10-22-2009 |